Network-1

Network-1 is focused on the acquisition, development, licensing and general enforcement of its intellectual property portfolio. We identify and acquire intellectual property from companies and inventors and implement industry-wide licensing programs on reasonable terms to enable widespread adoption. In this manner, Network-1 is able to maximize the value of the technologies and generate returns for the inventor's research and development investments. Inventors and firms that sell their intellectual property to Network-1 may retain a stake in the royalties generated by our licensing efforts. This enables them to protect and monetize their technology without the considerable expense and effort required to enforce intellectual property rights. Our goal is to maximize the value of our portfolio for the benefit of our shareholders and partners by generating high margin licensing revenues with limited operating risk and expenses.

Network-1, established in 1990 and headquartered in New York, New York, United States, North America., specializes in investments across Enterprise Software, Information Services, Information Technology, Biotechnology, Health Care, Pharmaceutical, Clinical Trials, Life Science, Manufacturing. Their recent investments include Lifestreams, ILiAD Biotechnologies, Seedlings Life Science Ventures. The highest investment round they participated in was $504.0M. Among their most notable exits are Lifestreams and ILiAD Biotechnologies. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.